Main ContentALPINE 2
Study title
Randomized double blind phase 3b trial to evaluate the safety and efficacy of 2 treatment regimens of aztreonam 75 mg powder and solvent for nebulizer solution azetronam for inhalation solution (ALZI)
- Principal Investigator: Dr. David Josey
Purpose
This study is evaluating an experimental drug in patients with cystic fibrosis and new onset respiratory tract Pseudomonas Aeruginosa infection.
Who can participate
Those eligible to participate in this study include:
- Male or female ages 3 months to less than 18 years with cystic fibrosis and new onset respiratory tract Pseudomonas Aeruginosa infection
For more information
- Cathy Hudgins
University of Mississippi Medical Center
2500 N. State St.
Jackson MS 39216
(601) 815-9276 - IRB Number: 2017-0246